Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Brain activation patterns and cognitive processing speed in patients with pediatric-onset multiple sclerosis.
Use of the VH6-1 gene segment to code for anti-interleukin-18 autoantibodies in multiple sclerosis.
Predictors of executive complaints and executive deficits in multiple sclerosis.
Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain.
Implication of matrix metalloproteinases in regulating neuronal disorder.
Dimethyl fumarat - a new player in oral treatment options for relapsing forms of multiple sclerosis.
The HV3 Score: A New Simple Tool to Suspect Cognitive Impairment in Multiple Sclerosis in Clinical Practice.
Relapsing-remitting multiple sclerosis: patterns of response to disease-modifying therapies and associated factors: a national survey.
Efficacy of high-dose vitamin D3 supplementation in vitamin D deficient pregnant women with multiple sclerosis: Preliminary findings of a randomized-controlled trial.
Update on Leukodystrophies: A Historical Perspective and Adapted Definition.
Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life.
The substrate of increased cortical FA in MS: A 7T post-mortem MRI and histopathology study.
Hes3 expression in the adult mouse brain is regulated during demyelination and remyelination.
Case centered analysis of Optic Neuritis following vaccines.
Myelin Proteolipid Protein Complexes with αv Integrin and AMPA Receptors In Vivo and Regulates AMPA-Dependent Oligodendrocyte Progenitor Cell Migration through the Modulation of Cell-Surface GluR2 Expression.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Multiple Sclerosis Associated Risk Factors: A Case-Control Study.
A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies.
Obesity and brain inflammation: a focus on multiple sclerosis.
Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity.
Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis.
Considerations for subgroups and phenocopies in complex disease genetics.
IL7Rα Expression and Upregulation by IFNβ in Dendritic Cell Subsets Is Haplotype-Dependent.
Axonal excitability in X-linked dominant Charcot Marie Tooth disease.
Patient expectations and experiences of multiple sclerosis interferon β-1a treatment: a longitudinal, observational study in routine UK clinical practice.
Pages
« first
‹ previous
…
650
651
652
653
654
655
656
657
658
…
next ›
last »